These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 29548750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y.
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [Abstract] [Full Text] [Related]

  • 3. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
    Yang JH, Bang MA, Jang CH, Jo GH, Jung SK, Ki SH.
    J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
    [Abstract] [Full Text] [Related]

  • 4. The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (Cajanus cajan (L.) Millsp.) Leaves on Regulating LDLR and PCSK9 Expression in HepG2 Cells.
    Chang HY, Wu JR, Gao WY, Lin HR, Chen PY, Chen CI, Wu MJ, Yen JH.
    Molecules; 2019 Jan 30; 24(3):. PubMed ID: 30704067
    [Abstract] [Full Text] [Related]

  • 5. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.
    Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH.
    Mol Nutr Food Res; 2014 Nov 30; 58(11):2133-45. PubMed ID: 25164566
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms.
    Xu RX, Liu J, Li XL, Li S, Zhang Y, Jia YJ, Sun J, Li JJ.
    J Transl Med; 2015 Mar 14; 13():87. PubMed ID: 25889684
    [Abstract] [Full Text] [Related]

  • 10. A Therapeutic Peptide Vaccine Against PCSK9.
    Pan Y, Zhou Y, Wu H, Chen X, Hu X, Zhang H, Zhou Z, Qiu Z, Liao Y.
    Sci Rep; 2017 Oct 02; 7(1):12534. PubMed ID: 28970592
    [Abstract] [Full Text] [Related]

  • 11. Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells.
    Lee KS, Kwon YS, Kim S, Moon DS, Kim HJ, Nam KS.
    Biomed Pharmacother; 2017 Feb 02; 86():405-413. PubMed ID: 28012395
    [Abstract] [Full Text] [Related]

  • 12. Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells.
    Choi HK, Hwang JT, Nam TG, Kim SH, Min DK, Park SW, Chung MY.
    Food Funct; 2017 Dec 13; 8(12):4582-4591. PubMed ID: 29130084
    [Abstract] [Full Text] [Related]

  • 13. 23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9.
    Li HH, Li J, Zhang XJ, Li JM, Xi C, Wang WQ, Lu YL, Xuan LJ.
    Acta Pharmacol Sin; 2020 Mar 13; 41(3):327-335. PubMed ID: 31358898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo.
    Gu L, Wang Y, Xu Y, Tian Q, Lei G, Zhao C, Gao Z, Pan Q, Zhao W, Nong L, Tan S.
    Oncotarget; 2017 Oct 06; 8(46):80826-80840. PubMed ID: 29113347
    [Abstract] [Full Text] [Related]

  • 16. Naringin Activates AMPK Resulting in Altered Expression of SREBPs, PCSK9, and LDLR To Reduce Body Weight in Obese C57BL/6J Mice.
    Sui GG, Xiao HB, Lu XY, Sun ZL.
    J Agric Food Chem; 2018 Aug 29; 66(34):8983-8990. PubMed ID: 30092639
    [Abstract] [Full Text] [Related]

  • 17. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D, Pöss J, Böhm M, Laufs U.
    J Am Coll Cardiol; 2013 Oct 15; 62(16):1401-8. PubMed ID: 23973703
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
    Yang SH, Xu RX, Cui CJ, Wang Y, Du Y, Chen ZG, Yao YH, Ma CY, Zhu CG, Guo YL, Wu NQ, Sun J, Chen BX, Li JJ.
    Cardiovasc Diabetol; 2018 Apr 04; 17(1):48. PubMed ID: 29618348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.